Stocks and Investing Stocks and Investing
Wed, March 6, 2019
Tue, March 5, 2019
Mon, March 4, 2019
Fri, March 1, 2019
Thu, February 28, 2019
Wed, February 27, 2019
Tue, February 26, 2019
Mon, February 25, 2019
Fri, February 22, 2019

Ian Somaiya Initiated (BIIB) at Hold and Held Target at $322 on, Feb 22nd, 2019


Published on 2024-10-26 12:14:24 -
  Print publication without navigation


Ian Somaiya of BMO Capital, Initiated "Biogen Inc." (BIIB) at Hold and Held Target at $322 on, Feb 22nd, 2019.

Ian has made no other calls on BIIB in the last 4 months.



There are 3 other peers that have a rating on BIIB. Out of the 3 peers that are also analyzing BIIB, 1 agrees with Ian's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Thomas Shrader of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $346 on, Thursday, February 21st, 2019


These are the ratings of the 2 analyists that currently disagree with Ian


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $401 on, Wednesday, December 19th, 2018
  • Cory Kasimov of "JP Morgan" Maintained at Buy with Decreased Target to $436 on, Wednesday, October 24th, 2018